---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-151234"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:49:23.224847+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve amendment to CalciMedica 2023 equity plan, adding 600,000 shares

## Summary
- Stockholders elected all three Class I director nominees: Leheny, Roberts, Guerard with over 9.5M votes each.
- Ratification of Baker Tilly as independent auditor for FY 2025 passed with 12.3M votes for, 135K against.
- Amendment to 2023 Equity Incentive Plan approved (8.9M for, 923K against), increasing authorized shares by 600,000.

## SEC filing metadata
- accession: 0001193125-25-151234
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312525151234/0001193125-25-151234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312525151234/d12150d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-151234
- JSON: https://secwatch.observer/filing/0001193125-25-151234.json
- Plain text: https://secwatch.observer/filing/0001193125-25-151234.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.